Background:Small extracellular vesicles(sEVs)mediate intercellular commu-nication that contributes to hepatocellular carcinoma(HCC)progression via multifaceted pathways.The success of cell entry determines the effect ...Background:Small extracellular vesicles(sEVs)mediate intercellular commu-nication that contributes to hepatocellular carcinoma(HCC)progression via multifaceted pathways.The success of cell entry determines the effect of sEV on recipient cells.Here,we aimed to delineate the mechanisms underlying the uptake of sEV in HCC.Abbreviations:AF,Alexa Fluor;ANOVA,analysis of variance;ATP9A,ATPase Phospholipid Transporting 9A;BCECF-AM,2’,7’-bis-(2-barboxyethyl)-5-(and-6)-carboxyfluorescein,acetoxymethyl ester;BSA,bovine serum albumin;CCMR,Centre for Comparative Medicine Research;CRISPR,clustered regularly interspaced short palindromic repeats;CTL,ctrl;CXCR4,C-X-C Chemokine Receptor Type 4;DAPI,4′,6-diamidino-2-phenylindole;DFS,disease-free survival;DMEM,Dulbecco’s Modified Eagle Medium;DMSO,dimethyl sulfoxide;Dox,doxycycline;EEA1,early endosome antigen 1;EIPA,5-(N-ethyl-N-isopropyl)-amiloride;FBS,fetal bovine serum;FITC,fluorescein isothiocyanate;GAPDH,glyceraldehyde-3-phosphate dehydrogenase;GM130,Golgi matrix protein 130;HCC,hepatocellular carcinoma;HEPES,4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid;HPRT1,hypoxanthine phosphoribosyltransferase 1;H-score,histoscore;IAA,indole-3-acetic acid;KD,knockdown;KO,knockout;mAID,mini-auxin-inducible degron;MTT,3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide;NHE7,Na(+)/H(+)exchanger 7;ns,non-significant;OD,optical density;OS,overall survival;PBS,phosphate-buffered saline;PCR,polymerase chain reaction;pHe,endosomal pH;pHi,intracellular pH;PKH67,Paul Karl Horan 67;Rab21,Ras-associated binding protein 21;RIPA,radioimmunoprecipitation assay;SAM,synergistic activation mediator;SEMs,standard error of the means;sEVs,small extracellular vesicles;sgRNA,single-guide RNA;shRNA,short-hairpin RNA;SLC9,solute carrier gene 9;SLiCE,Seamless Ligation Cloning Extract;TCGA,The Cancer Genome Atlas;TCL,total cell lysates;TGN,trans-Golgi network;TMA,tissue microarray;TMR,tetramethyl rhodamine;TSG101,tumor susceptibility gene 101.Yue Yao and Yi Xu contributed equally to this work.Methods:Macropinocytosis was examined by the ability of cells to internalize dextran and sEV.Macropinocytosis was analyzed in Na(+)/H(+)exchanger 7(NHE7)-knockdown and-overexpressing cells.The properties of cells were stud-ied using functional assays.pH biosensor was used to evaluate the intracellular and endosomal pH.The expression of NHE7 in patients’liver tissues was exam-ined by immunofluorescent staining.Inducible silencing of NHE7 in established tumors was performed to reveal the therapeutic potential of targeting NHE7.Results:The data revealed that macropinocytosis controlled the internaliza-tion of sEVs and their oncogenic effect on recipient cells.It was found that metastatic HCC cells exhibited the highest efficiency of sEV uptake relative to normal liver cells and non-metastatic HCC cells.Attenuation of macropinocytic activity by 5-(N-ethyl-N-isopropyl)-amiloride(EIPA)limited the entry of sEVs and compromised cell aggressiveness.Mechanistically,we delineated that high level of NHE7,a sodium-hydrogen exchanger,alkalized intracellular pH and acidized endosomal pH,leading to the maturation of macropinosomes.Inducible inhibition of NHE7 in established tumors developed in mice delayed tumor development and suppressed lung metastasis.Clinically,NHE7 expression was upregulated and linked to dismal prognosis of HCC.Conclusions:This study advances the understanding that NHE7 enhances sEV uptake by macropinocytosis to promote the malignant properties of HCC cells.Inhibition of sEV uptake via macropinocytosis can be exploited as a treatment alone or in combination with conventional therapeutic approaches for HCC.展开更多
Hepatocellular carcinoma(HCC)is one of the most common and highly heterogeneous malignancies worldwide.Despite the rapid development of multidisciplinary treatment and personalized precision medicine strategies,the ov...Hepatocellular carcinoma(HCC)is one of the most common and highly heterogeneous malignancies worldwide.Despite the rapid development of multidisciplinary treatment and personalized precision medicine strategies,the overall survival of HCC patients remains poor.The limited survival benefit may be attributed to difficulty in early diagnosis,the high recurrence rate and high tumor heterogeneity.Ferroptosis,a novel mode of cell death driven by iron-dependent lipid peroxidation,has been implicated in the development and therapeutic response of various tumors,including HCC.In this review,we discuss the regulatory network of ferroptosis,describe the crosstalk between ferroptosis and HCCrelated signaling pathways,and elucidate the potential role of ferroptosis in various treatment modalities for HCC,such as systemic therapy,radiotherapy,immunotherapy,interventional therapy and nanotherapy,and applications in the diagnosis and prognosis of HCC,to provide a theoretical basis for the diagnosis and treatment of HCC to effectively improve the survival of HCC patients.展开更多
Hepatocellular carcinoma(HCC)being a leading cause of cancer-related death,has high associated mortality and recurrence rates.It has been of great necessity and urgency to find effective HCC diagnosis and treatment me...Hepatocellular carcinoma(HCC)being a leading cause of cancer-related death,has high associated mortality and recurrence rates.It has been of great necessity and urgency to find effective HCC diagnosis and treatment measures.Studies have shown that microvascular invasion(MVI)is an independent risk factor for poor prognosis after hepatectomy.The abnormal expression of biomacromolecules such as circ-RNAs,lncRNAs,STIP1,and PD-L1 in HCC patients is strongly correlated with MVI.Deregulation of several markers mentioned in this review affects the proliferation,invasion,metastasis,EMT,and anti-apoptotic processes of HCC cells through multiple complex mechanisms.Therefore,these biomarkers may have an important clinical role and serve as promising interventional targets for HCC.In this review,we provide a comprehensive overview on the functions and regulatory mechanisms of MVI-related biomarkers in HCC.展开更多
Extracellular vesicles(EVs)are vesicular bodies that bud off from the cell membrane or are secreted virtually by all cell types.Small EVs(sEVs or exosomes)are key mediators of cell-cell communication by delivering the...Extracellular vesicles(EVs)are vesicular bodies that bud off from the cell membrane or are secreted virtually by all cell types.Small EVs(sEVs or exosomes)are key mediators of cell-cell communication by delivering their cargo,including proteins,lipids,or RNAs,to the recipient cells where they induce changes in signaling pathways and phenotypic prop-erties.Tangible findings have revealed the pivotal involve-ment of sEVs in the pathogenesis of various diseases.On the bright side,they are rich sources of biomarkers for diag-nosis,prognosis,treatment response,and disease monitor-ing.sEVs have high stability,biocompatibility,targetability,low toxicity,and are immunogenic in nature.Their intrinsic properties make sEVs an ideal delivery vehicle to be loaded with cargo for therapeutic interventions.Liver diseases are a major global health problem.This review aims to focus on the roles and mechanisms of sEVs in the pathogenesis of liver diseases,liver injury,liver failure,and liver can-cer.sEVs are released not only by hepatocytes but also by stromal and immune cells in the microenvironment.Early detection of liver disease determines the chance for cura-tive treatment and high survival of patients.This review focuses on the potential of circulating sEV cargo as specific and sensitive noninvasive biomarkers for the early detection and prognosis of liver diseases.In addition,the therapeutic use of sEVs derived from various cell types is discussed.Al-though sEVs hold promise for clinical applications,there are still challenges to be overcome by further research to bring utilization of sEVs into clinical practice.展开更多
基金The work was funded by Research Grants Council General Research Fund(Grant No.17105322)Hong Kong Scholars Program(Grant No.XJ2020012 and 2020-036)+3 种基金University Research Committee Seed Fund for Basic Research(Grant No.202111159009)of The University of Hong KongMarshal Initiative Fund-ing of Harbin Medical University(Grant No.HMUMIF-22008)Open Funds of State Key Laboratory of Oncology in South China(Grant No.HN2023-02)Natural Sci-ence Foundation of Heilongjiang Province(Grant No.LH2023H043).
文摘Background:Small extracellular vesicles(sEVs)mediate intercellular commu-nication that contributes to hepatocellular carcinoma(HCC)progression via multifaceted pathways.The success of cell entry determines the effect of sEV on recipient cells.Here,we aimed to delineate the mechanisms underlying the uptake of sEV in HCC.Abbreviations:AF,Alexa Fluor;ANOVA,analysis of variance;ATP9A,ATPase Phospholipid Transporting 9A;BCECF-AM,2’,7’-bis-(2-barboxyethyl)-5-(and-6)-carboxyfluorescein,acetoxymethyl ester;BSA,bovine serum albumin;CCMR,Centre for Comparative Medicine Research;CRISPR,clustered regularly interspaced short palindromic repeats;CTL,ctrl;CXCR4,C-X-C Chemokine Receptor Type 4;DAPI,4′,6-diamidino-2-phenylindole;DFS,disease-free survival;DMEM,Dulbecco’s Modified Eagle Medium;DMSO,dimethyl sulfoxide;Dox,doxycycline;EEA1,early endosome antigen 1;EIPA,5-(N-ethyl-N-isopropyl)-amiloride;FBS,fetal bovine serum;FITC,fluorescein isothiocyanate;GAPDH,glyceraldehyde-3-phosphate dehydrogenase;GM130,Golgi matrix protein 130;HCC,hepatocellular carcinoma;HEPES,4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid;HPRT1,hypoxanthine phosphoribosyltransferase 1;H-score,histoscore;IAA,indole-3-acetic acid;KD,knockdown;KO,knockout;mAID,mini-auxin-inducible degron;MTT,3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide;NHE7,Na(+)/H(+)exchanger 7;ns,non-significant;OD,optical density;OS,overall survival;PBS,phosphate-buffered saline;PCR,polymerase chain reaction;pHe,endosomal pH;pHi,intracellular pH;PKH67,Paul Karl Horan 67;Rab21,Ras-associated binding protein 21;RIPA,radioimmunoprecipitation assay;SAM,synergistic activation mediator;SEMs,standard error of the means;sEVs,small extracellular vesicles;sgRNA,single-guide RNA;shRNA,short-hairpin RNA;SLC9,solute carrier gene 9;SLiCE,Seamless Ligation Cloning Extract;TCGA,The Cancer Genome Atlas;TCL,total cell lysates;TGN,trans-Golgi network;TMA,tissue microarray;TMR,tetramethyl rhodamine;TSG101,tumor susceptibility gene 101.Yue Yao and Yi Xu contributed equally to this work.Methods:Macropinocytosis was examined by the ability of cells to internalize dextran and sEV.Macropinocytosis was analyzed in Na(+)/H(+)exchanger 7(NHE7)-knockdown and-overexpressing cells.The properties of cells were stud-ied using functional assays.pH biosensor was used to evaluate the intracellular and endosomal pH.The expression of NHE7 in patients’liver tissues was exam-ined by immunofluorescent staining.Inducible silencing of NHE7 in established tumors was performed to reveal the therapeutic potential of targeting NHE7.Results:The data revealed that macropinocytosis controlled the internaliza-tion of sEVs and their oncogenic effect on recipient cells.It was found that metastatic HCC cells exhibited the highest efficiency of sEV uptake relative to normal liver cells and non-metastatic HCC cells.Attenuation of macropinocytic activity by 5-(N-ethyl-N-isopropyl)-amiloride(EIPA)limited the entry of sEVs and compromised cell aggressiveness.Mechanistically,we delineated that high level of NHE7,a sodium-hydrogen exchanger,alkalized intracellular pH and acidized endosomal pH,leading to the maturation of macropinosomes.Inducible inhibition of NHE7 in established tumors developed in mice delayed tumor development and suppressed lung metastasis.Clinically,NHE7 expression was upregulated and linked to dismal prognosis of HCC.Conclusions:This study advances the understanding that NHE7 enhances sEV uptake by macropinocytosis to promote the malignant properties of HCC cells.Inhibition of sEV uptake via macropinocytosis can be exploited as a treatment alone or in combination with conventional therapeutic approaches for HCC.
基金Hong Kong Scholars Program (Grant No.XJ2020012)National Natural Science Foundation of China (Grant No.81902431)+8 种基金Excellent Youth Project of Natural Science Foundation of Heilongjiang (Grant No.YQ2019H007)Special Project of China Postdoctoral Science Foundation (Grant No.2019T120279)Special Project of Heilongjiang Postdoctoral Science Foundation (Grant No.LBH-TZ1016)China Postdoctoral Science Foundation (Grant No.2018M641849 and 2018M640311)Heilongjiang Postdoctoral Science Foundation (Grant No.LBH-Z18107 and LBH-Z18112)The Fundamental Research Funds for the Heilongjiang Provincial Universities (Grant No.2018-KYYWF-0511 and 2018-KYYWF-0498)Postgraduate Innovative Research Project of Harbin Medical University (Grant No.YJSCX2016-21HYD)Foundation of Key Laboratory of Myocardial Ischemia,Ministry of Education (Grant No.KF201810)Chen Xiaoping Foundation for the Development of Science and Technology of Hubei Province (Grant No.CXPJJH11800004-001 and CXPJJH11800004-003).
文摘Hepatocellular carcinoma(HCC)is one of the most common and highly heterogeneous malignancies worldwide.Despite the rapid development of multidisciplinary treatment and personalized precision medicine strategies,the overall survival of HCC patients remains poor.The limited survival benefit may be attributed to difficulty in early diagnosis,the high recurrence rate and high tumor heterogeneity.Ferroptosis,a novel mode of cell death driven by iron-dependent lipid peroxidation,has been implicated in the development and therapeutic response of various tumors,including HCC.In this review,we discuss the regulatory network of ferroptosis,describe the crosstalk between ferroptosis and HCCrelated signaling pathways,and elucidate the potential role of ferroptosis in various treatment modalities for HCC,such as systemic therapy,radiotherapy,immunotherapy,interventional therapy and nanotherapy,and applications in the diagnosis and prognosis of HCC,to provide a theoretical basis for the diagnosis and treatment of HCC to effectively improve the survival of HCC patients.
基金supported by the Hong Kong Scholars Program(Grant No.XJ2020012)Beijing Xisike Clinical Oncology Research Foundation(Grant No.Y-Young2022-0188)+11 种基金Medjaden Academy&Research Foundation for Young Scientists(Grant No.MJR20220903)Strengthening and Enhancing the Efficiency Plan of the Dominant and Characteristic Disciplines of Harbin Medical University(Grant No.HMUMIF-22008)Opening Project of State Key Laboratory of Chemical Oncogenomics,Opening Project of Key Laboratory of Basic Pharmacology of Ministry of Education,Zunyi Medicial University(Grant No.2022-449)Opening Research Fund of Key Laboratory of Gastrointestinal Cancer,Fujian Medical University,Ministry of Education(Grant No.FMUGIC-202203)Opening Project of Key Laboratory of Environment and Health,Ministry of Education(Grant No.2022GWKFJJ01)Opening Project of Key Laboratory of Functional and Clinical Translational Medicine,Fujian Province University(Grant No.XMMC-FCTM202205)Opening Project of Guangxi Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer(Grant No.GXEKL202204)Opening Project of Key Laboratory of Biomarkers and In Vitro Diagnosis Translation of Zhejiang Province(Grant No.KFJJ-2022002)Opening Project of Jiangsu Province Engineering Research Center of Tumor Targeted Nano Diagnostic and Therapeutic Materials(Grant No.JETNM202210)Thematic Research Support Scheme of State Key Laboratory of Liver Research,The University of Hong Kong(SKLLR/TRSS/2022/08)Opening Project of Key Laboratory of Intelligent Pharmacy and Individualized Therapy of Huzhou&Changxing Anti-cancer Association(NZKF-20230203)Opening Project of Fujian Provincial Key Laboratory of Innovative Drug Target Research(FJ-YW-2022KF03).
文摘Hepatocellular carcinoma(HCC)being a leading cause of cancer-related death,has high associated mortality and recurrence rates.It has been of great necessity and urgency to find effective HCC diagnosis and treatment measures.Studies have shown that microvascular invasion(MVI)is an independent risk factor for poor prognosis after hepatectomy.The abnormal expression of biomacromolecules such as circ-RNAs,lncRNAs,STIP1,and PD-L1 in HCC patients is strongly correlated with MVI.Deregulation of several markers mentioned in this review affects the proliferation,invasion,metastasis,EMT,and anti-apoptotic processes of HCC cells through multiple complex mechanisms.Therefore,these biomarkers may have an important clinical role and serve as promising interventional targets for HCC.In this review,we provide a comprehensive overview on the functions and regulatory mechanisms of MVI-related biomarkers in HCC.
基金National Natural Science Foun-dation of China General Program(Grant numbers:81872340 and 82072626).
文摘Extracellular vesicles(EVs)are vesicular bodies that bud off from the cell membrane or are secreted virtually by all cell types.Small EVs(sEVs or exosomes)are key mediators of cell-cell communication by delivering their cargo,including proteins,lipids,or RNAs,to the recipient cells where they induce changes in signaling pathways and phenotypic prop-erties.Tangible findings have revealed the pivotal involve-ment of sEVs in the pathogenesis of various diseases.On the bright side,they are rich sources of biomarkers for diag-nosis,prognosis,treatment response,and disease monitor-ing.sEVs have high stability,biocompatibility,targetability,low toxicity,and are immunogenic in nature.Their intrinsic properties make sEVs an ideal delivery vehicle to be loaded with cargo for therapeutic interventions.Liver diseases are a major global health problem.This review aims to focus on the roles and mechanisms of sEVs in the pathogenesis of liver diseases,liver injury,liver failure,and liver can-cer.sEVs are released not only by hepatocytes but also by stromal and immune cells in the microenvironment.Early detection of liver disease determines the chance for cura-tive treatment and high survival of patients.This review focuses on the potential of circulating sEV cargo as specific and sensitive noninvasive biomarkers for the early detection and prognosis of liver diseases.In addition,the therapeutic use of sEVs derived from various cell types is discussed.Al-though sEVs hold promise for clinical applications,there are still challenges to be overcome by further research to bring utilization of sEVs into clinical practice.